Valuation: LifeVantage Corporation

Market Cap 78.85M 69.23M 63.72M 59.38M 112M 7.5B 114M 766M 297M 3.68B 296M 290M 12.81B P/E 2026 *
14.9x
P/E 2027 * 16x
Enterprise Value 65.3M 57.33M 52.77M 49.17M 92.74M 6.21B 94.62M 635M 246M 3.05B 245M 240M 10.61B EV / Sales 2026 *
0.35x
EV / Sales 2027 * 0.36x
Free-Float
83.58%
Yield 2026 *
-
Yield 2027 * -
1 day+0.16%
1 week+0.32%
Current month+0.16%
1 month-33.72%
3 months+48.81%
6 months+1.46%
Current year+1.46%
1 week 6.16
Extreme 6.1577
7
1 month 5.52
Extreme 5.52
11.36
Current year 3.9
Extreme 3.9
11.71
1 year 3.9
Extreme 3.9
15
3 years 3.9
Extreme 3.9
27.38
5 years 3.04
Extreme 3.04
27.38
10 years 2.86
Extreme 2.86
27.38
Manager TitleAgeSince
Chief Executive Officer 74 2026-04-29
Director of Finance/CFO 53 2021-10-24
Chief Tech/Sci/R&D Officer - 2026-01-06
Director TitleAgeSince
Director/Board Member 74 2011-12-31
Director/Board Member 67 2017-01-31
Director/Board Member 68 2022-02-16
Date Insider Type Main position Quantity % Market Cap.
06-14Buy

Director

705 0.0056%
06-02Sell

Chief Executive Officer

-10,000 0.0793%
03-31Tax

Chief Financial Officer

1,527 0.0119%
Change 5-day change 1-year change 3-year change Capi.($)
+0.16%+0.32%-53.32%+43.68% 78.85M
-0.64%+6.67%+53.59%+154.11% 1,063B
+0.00%+5.39%+62.89%+53.44% 611B
-0.23%+6.88%+32.14%+86.34% 444B
+1.99%-0.96%+26.12%+20.22% 324B
+1.98%+0.27%+35.71%+35.92% 285B
+0.88%-0.14%+27.83%+42.11% 283B
-0.07%+2.15%-26.96%-40.43% 219B
-0.22%+2.82%+24.37%+62.75% 195B
-0.29%+0.65%+12.75%+63.45% 156B
Average +0.55%+2.58%+19.51%+52.16% 358.08B
Weighted average by Cap. +0.62%+4.16%+38.27%+77.30%

Financials

2026 *2027 *
Net sales 184M 162M 149M 139M 262M 17.51B 267M 1.79B 694M 8.6B 692M 677M 29.91B 178M 157M 144M 134M 253M 16.96B 258M 1.73B 672M 8.32B 670M 655M 28.97B
Net income 5.3M 4.65M 4.28M 3.99M 7.53M 504M 7.68M 51.52M 19.96M 247M 19.9M 19.47M 861M 4.9M 4.3M 3.96M 3.69M 6.96M 466M 7.1M 47.63M 18.45M 229M 18.4M 18M 796M
Net Debt -13.55M -11.9M -10.95M -10.2M -19.24M -1.29B -19.64M -132M -51.03M -632M -50.88M -49.78M -2.2B -15M -13.17M -12.12M -11.29M -21.3M -1.43B -21.73M -146M -56.47M -700M -56.3M -55.08M -2.44B
Logo LifeVantage Corporation
LifeVantage Corporation is an activation company, which is engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.
Employees
235
Date Price Change Volume
26-07-01 US$6.250 +0.16% 191,328
26-06-30 US$6.240 +0.65% 151,903
26-06-29 US$6.200 -6.34% 188,704
26-06-26 US$6.620 -0.45% 1,702,362
26-06-25 US$6.650 +6.74% 172,979
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
6.250USD
Average target price
7.000USD
Spread / Average Target
+12.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LFVN Stock